272 related articles for article (PubMed ID: 29600480)
1. Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.
Hou A; Li L; Huang Y; Singh V; Zhu C; Pan X; Quan G; Wu C
Drug Deliv Transl Res; 2018 Jun; 8(3):693-701. PubMed ID: 29600480
[TBL] [Abstract][Full Text] [Related]
2. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
3. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
4. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
5. Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides.
Eedara BB; Alabsi W; Encinas-Basurto D; Polt R; Mansour HM
AAPS PharmSciTech; 2021 Jun; 22(5):185. PubMed ID: 34143327
[TBL] [Abstract][Full Text] [Related]
6. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
[TBL] [Abstract][Full Text] [Related]
7. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
[TBL] [Abstract][Full Text] [Related]
8. [Development of an Inhalation Dry Powder Preparation Method without Heat-drying Process].
Ito T
Yakugaku Zasshi; 2023; 143(4):353-358. PubMed ID: 37005236
[TBL] [Abstract][Full Text] [Related]
9. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.
Moon C; Watts AB; Lu X; Su Y; Williams RO
Mol Pharm; 2019 May; 16(5):1799-1812. PubMed ID: 30925839
[TBL] [Abstract][Full Text] [Related]
11. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
[TBL] [Abstract][Full Text] [Related]
12. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
[TBL] [Abstract][Full Text] [Related]
13. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
[TBL] [Abstract][Full Text] [Related]
14. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
[TBL] [Abstract][Full Text] [Related]
15. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
Kaialy W; Nokhodchi A
Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318
[TBL] [Abstract][Full Text] [Related]
16. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
Saboti D; Maver U; Chan HK; Planinšek O
J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
[TBL] [Abstract][Full Text] [Related]
17. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
[TBL] [Abstract][Full Text] [Related]
18. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
[TBL] [Abstract][Full Text] [Related]
19. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
Wu X; Zhang W; Hayes D; Mansour HM
Int J Nanomedicine; 2013; 8():1269-83. PubMed ID: 23569375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
